Lipids and homocysteine level in juvenile idiopathic arthritis;Ocena wybranych parametrów gospodarki lipidowej i homocysteiny w młodzieńczym idiopatycznym zapaleniu stawów u dzieci

Polski Merkuriusz Lekarski

Volumn 17, Issue 99, 2004, Pages 235-238

  Urban, Mirosława ^a   Pietrewicz, Edyta ^a   Górska, Anna ^a   Głowińska, Barbara ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adverse lipids profile; Atherosclerosis; Homocysteine; Juvenile idiopathic arthritis

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTHRITIS; ARTICLE; ATHEROSCLEROSIS; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION COEFFICIENT; FEMALE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LIPID BLOOD LEVEL; MALE; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; ARTHRITIS, JUVENILE RHEUMATOID; C-REACTIVE PROTEIN; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HOMOCYSTEINE; HUMANS; MALE; TRIGLYCERIDES;

EID: 5444232610     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Bacon P., Kitas G.: Rheumatoid arthritis, vasculitis and atherosclerosis. W: Atherosclerosis and autoimmunity. Shoenfeld Y., Harats D., Wick G. (red.) Elsevier, 2001, 301-313.
2. Bacon P., Raza K., Banks M.J. i wsp.: The role of endothelial cell dysfunction in the cardiovascular mortality of RA. Int. Rev. Immunol., 2002 21 (1), 1-17.
3. Bakkaloglu A., Kirel B., Ozen S. i wsp.: Plasma lipids and lipoprotein in juvenile chronic arthritis. Clin. Rheum., 1996, 15 (4), 341-345.
4. De Maria A.: Relative risk of cardiovascular events in patients with rheumatoid arthritis. Am. J. Cardiol., 2002, 89 (suppl.), 33D-38D.
5. Dessein P.H., Joffe B.I., Stanvix A. i wsp.: The acute phase response not fully predict the presence of insulin resistance and dyslipidemia in inflammatory arthritis. J. Rheumatol., 2002, 29 (3), 462-466.
6. Fraser D.A., Thoen J., Bondhus S. i wsp.: Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after ketogenic diet in rheumatoid arthritis patients. Clin. Exp. Rheum., 2000, 18 (2), 209-214.
7. Gazarin M., Feldman L., Benson L.: Assesment of myocardial perfusion and function in children with SLE. J. Pediatr., 1998, 132, 109-116.
8. George J., Afek A., Gilburd B. i wsp.: Autoimmunity in atherosclerosis, lessons from experimental models. Lupus, 2000, 9 (3), 223-227.
9. Goodson N.: Coronary artery disease and rheumatoid arthritis. Curr. Opin. Rheumatol., 2002, 14 (2), 115-120.
10. Hankey G.J., Eikelboom J.W.: Homocysteine and vascular disease. Lancet, 1999, 31, 354.
11. Hurt-Camejo E., Paredes S., Masana L. i wsp.: Elevated levels of small, low-density lipoprotein with high affinity for arterial matrix components in patients with rheumatoid arthritis, possible contribution of phospholipase 2 to this atherogenic profilel Arthritis Rheum., 2001, 44 (12), 2707-2710.
12. Ilowite N.T.: Premature atherosclerosis in systemic lupus erythematosus. J. Rheum., 2000, 27, Suppl. 58 (11), 15-19.
13. Ilowite N., Beseler S., Jacobs M.: Dyslipoproteinemia in juvenile rheumatoid arthritis. J. Pediatr., 1989, 114, 823-826.
14. Ilowite N.T., Samuel P., Ginzler E.: Dyslipoproteinemias in pediatric systemic lupus erythematosus. Arthritis Rheum., 1988, 31, 859-863.
15. Jeanette J.C., Falk R.J., Andrassay K. i wsp.: Nomenclature of systemic vasculitides, the proposal of an international consensus conference. Arthritis Rheum., 1994, 37,187-192.
16. Jonsson SW., Backman C., Johnson O. i wsp.: Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J. Rheumatol., 2001, 28 (12), 2597-602.
17. Kumeda Y., Inaba M., Goto H. i wsp.: Increased thickness of arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum., 2002, 46 (6), 1489-1497.
18. Kutukculer N., Caglayan S., Aydogdu F.: Study of pro-imfammatory (TNF-alpha, IL-1 alpha, IL-6) and T-cell-derived (IL-2, IL-4) cytokines in plasma and synovial fluid of patients with juvenile chronic arthritis, correlation with clinical and laboratory parameters. Clin. Rheumatol., 1998, 17 (4), 288-292.
19. Linos A., Kaklamani VG., Kaklamani E. i wsp.: Dietary factors in relation to rheumatoid arthritis, a rote for olive oil and cooked vegetables? Am. J. Clin. Nutr., 1999, 70 (6), 1077-1082.
20. Loscalzo J.: The oxidant stress of hyperhomocyst(e)inemia. J. Clin. Invest., 1996, 98, 5-7.
21. Meyer O.: Atherosclerosis and connective tissue diseases. Joint Bone Spine, 2001, 68 (6), 564-575.
22. Mietus-Snyder M., Malloy M.J.: Endothelial dysfunction occurs in children with to genetic hyperlipidemias, improvement with antioxidant vitamin therapy. J. Pediatr., 1998, 133, 35-40.
23. Milojevic D., Ilovite N.: Dyslipoproteinemia and premature atherosclerosis in the pediatric rheumatoid diseases. W: Atherosclerosis and autoimmunity. Shoenfeld Y., Harats D., Wick G. (red.) Elsevier, 2001, 329-333.
24. Park YB., Ahn CW., Choi HK. i wsp.: Atherosclerosis in rheumatoid arthritis, morphologic evidence obtained by carotid ultrasound. Arthritis Rheum., 2002, 46 (7), 1714-1719.
25. Park Y., Lee SK., Lee WK. i wsp.: Lipid profiles in untreated patients with rheumatoid arthritis. J. Rheumatol., 1999, 26, 1701-1714.
26. Pasceri V., Yen E.T.: A tale of two diseases, atherosclerosis and rheumatoid arthritis. Circulation, 1999, 29, 100, 2124-2126.
27. Petri M., Roubenoff R., Dullal G.: Plasma homocysteine as risk factor for atherosclerotic events in SLE. J. Rheumatol., 1995, 22, 450-454.
28. Petty R.E., Southwood T.R., Baum J. i wsp.: Revision of the proposed classification criteria forjuvenile idiopathic arthritis. Durban 1997. J. Rheumatol., 1998, 25, 1991-1994.
29. Pockley G.: Heat shock protein, inflammation and atherosclerosis. Circulation, 2002, 105, 1012-1017.
30. Ricon I.D., Wiliams K., Stern M.P. i wsp.: High incidence of cardiovascular events in rheumatoid arthritis cohort not explained by traditional risk factors. Arthritis Rheum. 2001, 44 (12), 2737-2745.
31. Ridker P.M., Hennekens C.H., Buring J.E. i wsp.: C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. Med., 2000, 342, 836-843.
32. Seriolo B., Fasciolo D., Sulli A. i wsp.: Homocysteine and antiphospholipid antibodies in rheumatoid arthritis, relationship with thrombotic events. Clin. Exp. Rheumatol., 2001, 19, 5, 561-564.
33. Tselepis A.D., Elisaf M., Besis S. i wsp.: Association of the inflammatory state in active juvenile rheumatoid arthritis with hypo-high-density lipoproteinemia and reduced lipoprotein-associated platelet-activating factor acetylhydrolase activity. Arthritis Rheum., 1999, 42 (2), 373-383.
34. Van Doornum S., Mc Coll G., Jenkins A. i wsp.: Screening for atherosclerosis in patients with rheumatoid arthritis, comparison of two In vivo tests of vascular function. Arthritis Rheum., 2003, 48 (1), 72-80.
35. Van Doornum S., Mc Coll G., Wicks I.P.: Accelerated atherosclerosis, an extraarticular feature of rheumatoid arthritis. Arthritis Rheum., 2002, 46 (4), 862-873.
36. Wallberg-Jonsson S., Cvetkovic J.T., Sundqvist K.G. i wsp.: Activation of the immune system and inflammation activity in relation to markers of atherothrombotic disease and atherosclerosis in rheumatoid arthritis. Rheumatol., 2002, 29 (5), 875-882.
37. Watkins S., German B., Shoenfeld Y i wsp.: Lipids and immunity. Autoimmunology, 2001, 87-111.